| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/05/2005 | EP0996619B1 Tropane analogs and methods for inhibition of monoamine transport |
| 01/05/2005 | EP0996451B1 Triterpene saponin analogs having adjuvant and immunostimulatory activity |
| 01/05/2005 | EP0957914B1 Formulation of 5-ht agonists |
| 01/05/2005 | EP0912196B9 Use of a thexaphyrin in the preparation of a medicament for use with a chemotherapeutic agent in cancer chemosensitization |
| 01/05/2005 | EP0881891B1 Male contraceptive implant |
| 01/05/2005 | EP0682517B1 Photodynamic treatment of synovium |
| 01/05/2005 | DE202004015931U1 Omega-3-Fettsäuren und Omega-6-Fettsäuren enthaltende Zusammensetzung Omega-3 fatty acids and omega-6 fatty acids containing composition |
| 01/05/2005 | DE19957065B4 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 01/05/2005 | DE10327674A1 Injizierbare Darreichungsform von Flupirtin Injectable dosage form of flupirtine |
| 01/05/2005 | DE10327428A1 Preparation of pyrrolidine-1,2-dicarboxanilide derivatives for use as factor Xa inhibiting antithrombotic agents, comprises reacting pyrrolidine-2-carboxylic acid with phenyl isocyanate then aniline derivative |
| 01/05/2005 | DE10326821A1 Pharmazeutische Kombinationspräparate zur Krebstherapie Pharmaceutical combination preparations for cancer therapy |
| 01/05/2005 | DE10325989A1 Verfahren zur Herstellung von und daraus resultierende Mikropellets sowie deren Verwendung A process for preparing and resulting micropellets and their use |
| 01/05/2005 | DE10325813A1 Prophylaxe und/oder Therapie bei der portalen Hypertonie Prophylaxis and / or therapy of portal hypertension in |
| 01/05/2005 | DE10297329T5 Dexibuprofen enthaltende Weichgelatinekapseln und Verfahren zu ihrer Herstellung Dexibuprofen-containing soft gelatin capsules and methods for their preparation |
| 01/05/2005 | DE102004028805A1 Mittel zur Förderung der Collagenbildung Means to promote collagen formation |
| 01/05/2005 | CN1561393A Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma |
| 01/05/2005 | CN1561344A Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 01/05/2005 | CN1561342A Novel macrolide derivative having effect of potentiating anti-fungus activity |
| 01/05/2005 | CN1561339A Process for preparing pyridyl-alkylsulfonyl pyrazole derivatives |
| 01/05/2005 | CN1561338A Chroman derivatives as 5-hydroxytryptamine-6 ligands |
| 01/05/2005 | CN1561336A Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 01/05/2005 | CN1561334A Indole derivatives as COXII inhibitors |
| 01/05/2005 | CN1561332A Preparation of HIV protease inhibitors |
| 01/05/2005 | CN1561331A Diaryl sulfide derivative, addition salt thereof, and immunosuppressant |
| 01/05/2005 | CN1561327A Novel aminobenzoephenones |
| 01/05/2005 | CN1561246A Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease |
| 01/05/2005 | CN1561231A Inhibition of neonatal hyperbilirubinemia in breast fed infants |
| 01/05/2005 | CN1561229A Virus coat protein/receptor chimeras and methods of use |
| 01/05/2005 | CN1561228A Enhancing organ maturity in neonates and predicting their duration of intensive care |
| 01/05/2005 | CN1561227A Method for treating hepatitis C virus infection in treatment failure patients |
| 01/05/2005 | CN1561220A Method for the treatment of inflammation |
| 01/05/2005 | CN1561219A Pharmaceutical compounds |
| 01/05/2005 | CN1561218A Enteral compositions for the prevention and/or treatment of sepsis |
| 01/05/2005 | CN1561217A Estrogen/gestagen combination preparation and application thereof |
| 01/05/2005 | CN1561216A Novel compounds |
| 01/05/2005 | CN1561215A Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid compounds used as nmda antagonist |
| 01/05/2005 | CN1561214A New formulations and use thereof |
| 01/05/2005 | CN1561213A New formulations and use thereof |
| 01/05/2005 | CN1561212A Benzimidazolidinone derivatives as muscarinic agents |
| 01/05/2005 | CN1561211A Nociceptin analogs |
| 01/05/2005 | CN1561210A Preparation of selective epoxide hydrolase II inhibitor |
| 01/05/2005 | CN1561209A Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same |
| 01/05/2005 | CN1561208A Methods to mobilize progenitor/stem cells |
| 01/05/2005 | CN1561207A Therapeutic delivery of carbon monoxide |
| 01/05/2005 | CN1561206A Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction |
| 01/05/2005 | CN1561205A Use of (R)-ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs |
| 01/05/2005 | CN1561204A Use of COX-2 inhibitors for preventing immunodeficiency |
| 01/05/2005 | CN1561203A Pharmaceutical salts |
| 01/05/2005 | CN1561202A Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same |
| 01/05/2005 | CN1561201A Pharmaceutical compositions comprising colloidal silicon dioxide |
| 01/05/2005 | CN1561200A Flashmelt oral dosage formulation |
| 01/05/2005 | CN1561198A Surfactant compounds and uses thereof |
| 01/05/2005 | CN1561168A Stable and bioavailable iron fortified beverages |
| 01/05/2005 | CN1561164A 抗微生物剂 Antimicrobial agent |
| 01/05/2005 | CN1561162A Highly crosslinked biocidal polystyrene hydantoin particles |
| 01/05/2005 | CN1560266A Preparation process of rise bran polysaccharose kind active component |
| 01/05/2005 | CN1560249A Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 01/05/2005 | CN1560064A Derivative of vibothymidine and its preparation process and application |
| 01/05/2005 | CN1560061A Process for extracting dioscored soap oside from dioscorea |
| 01/05/2005 | CN1560060A Synthesis for compound of diamine bridge linking ortho phenanthroline hydrous lanthanum (III) and anti-cancer activity thereof |
| 01/05/2005 | CN1560055A Tetrahydropyridoethers |
| 01/05/2005 | CN1560051A 取代吡唑化合物 A substituted pyrazole compound |
| 01/05/2005 | CN1560050A Derivative of phenylamide pyrimidine and application thereof |
| 01/05/2005 | CN1560044A Compound of 3, 15-dicarbonyl erythro mildew acid kind and its ester and salt |
| 01/05/2005 | CN1560041A Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 01/05/2005 | CN1560035A 5-hydroxylic indole-3-carboxylic ester kind derivantion |
| 01/05/2005 | CN1560032A Sultonyl (thio)urea derivants, their preparation process and pharmaceutical composition containing them |
| 01/05/2005 | CN1560024A Composite of functional fatty acid, amino acid and preparation process thereof |
| 01/05/2005 | CN1560018A 2-(alpha-n-pentanone) phenmethyl and its preparation process and application |
| 01/05/2005 | CN1560003A Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid |
| 01/05/2005 | CN1560000A Extraction process for total phenolic acid of salvia root and pharmacutical application thereof |
| 01/05/2005 | CN1559614A Dolysaccharide nanometer anticancer material and its preparation method |
| 01/05/2005 | CN1559612A Medicinal mixture for treating digestire system anabrosis |
| 01/05/2005 | CN1559539A Medicinal mixture possessing alpha glycocidase inhibiting activity and its use |
| 01/05/2005 | CN1559526A Medicine for strengthening child and dispersing food and its preparation method |
| 01/05/2005 | CN1559498A Ginkgo leaf extract and bimidamo oral compound medicine and its preparation method |
| 01/05/2005 | CN1559476A Medicinal health protection product |
| 01/05/2005 | CN1559443A Sturgeon chondroition capsule and instant granula prepn. method therefor |
| 01/05/2005 | CN1559433A Polyhexose type nanometer antimicrobial matter, prepn. method and use thereof |
| 01/05/2005 | CN1559432A Medicine for treating infantile enterorrhea |
| 01/05/2005 | CN1559431A Disperse tablet contg. klinemycin hydrochloride palmitate, and its prepn. method |
| 01/05/2005 | CN1559430A Prepn. of large volume infusion contg. Xi-Duo-Fu-Wei |
| 01/05/2005 | CN1559429A Freezing-drying powder injectiong contg. Xi-Duo-Fu-Wei |
| 01/05/2005 | CN1559428A Complex medicine for eliminating pyloric spirillar bacilli contg. secnidazole |
| 01/05/2005 | CN1559427A Medicine compound for treating cardiovascular and cerebrovascular diseases |
| 01/05/2005 | CN1559426A Medicine compound for treating cardiovascular and cerebrovascular diseases |
| 01/05/2005 | CN1559425A Method for preparing Baicalin prepn. for external use |
| 01/05/2005 | CN1559424A Erigeron breviscapus extraction dry suspensoid agent |
| 01/05/2005 | CN1559423A Oral effervesce tablets for treating cardiovascular and cerebrovascular diseases, and prepn. method therefor |
| 01/05/2005 | CN1559422A Oral medicine for eliminating pyloric spirillar bacilli |
| 01/05/2005 | CN1559421A Medicine compound contg. troxeration |
| 01/05/2005 | CN1559420A Medicne tablets with function of delaying senility, and prepn. method therefor |
| 01/05/2005 | CN1559419A Application of saponin of Bolbostemma paniculatum Franquet for preparing medicine for treating malignant tumour |
| 01/05/2005 | CN1559418A Pripping pills of gastrodin, and prepn. method therefor |
| 01/05/2005 | CN1559417A Gastrodin venous injection liquid, and its prepn. method |
| 01/05/2005 | CN1559416A Dripping pills of acetyl-gastrodin, and prepn. method therefor |
| 01/05/2005 | CN1559415A Application of ligo-xylose in preparing medicine for treating enteric function disturbance |
| 01/05/2005 | CN1559414A Application oligo-xylose in preparing medicine for treating chronic hepatitis accompanying enteric functon disturbance |
| 01/05/2005 | CN1559413A Freezing-drying powder-injection contg. dexamethasone sodium phosphate, and its prepn. method |
| 01/05/2005 | CN1559412A Freezing-drying powder-injection contg. sodium folinate, and its prepn. method |